MacroGenics, Inc. (MGNX)
4.14
+0.01
(+0.24%)
USD |
NASDAQ |
Sep 18, 16:00
4.14
0.00 (0.00%)
Pre-Market: 20:00
MacroGenics Cash from Operations (Quarterly) : -40.75M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -40.75M |
| March 31, 2026 | -35.81M |
| December 31, 2025 | 43.02M |
| September 30, 2025 | -30.19M |
| June 30, 2025 | -46.98M |
| March 31, 2025 | -46.89M |
| December 31, 2024 | -38.41M |
| September 30, 2024 | 60.16M |
| June 30, 2024 | -44.48M |
| March 31, 2024 | -45.64M |
| December 31, 2023 | -28.04M |
| September 30, 2023 | -35.25M |
| June 30, 2023 | -2.089M |
| March 31, 2023 | -12.83M |
| December 31, 2022 | 29.32M |
| September 30, 2022 | -9.422M |
| June 30, 2022 | -49.16M |
| March 31, 2022 | -57.70M |
| December 31, 2021 | -54.31M |
| September 30, 2021 | -14.80M |
| June 30, 2021 | -45.69M |
| March 31, 2021 | -29.04M |
| December 31, 2020 | -5.533M |
| September 30, 2020 | -25.68M |
| June 30, 2020 | -36.55M |
| Date | Value |
|---|---|
| March 31, 2020 | -44.14M |
| December 31, 2019 | -38.04M |
| September 30, 2019 | -17.39M |
| June 30, 2019 | -48.84M |
| March 31, 2019 | -30.00M |
| December 31, 2018 | -27.23M |
| September 30, 2018 | -36.98M |
| June 30, 2018 | -57.73M |
| March 31, 2018 | -31.30M |
| December 31, 2017 | 111.84M |
| September 30, 2017 | -31.35M |
| June 30, 2017 | -30.76M |
| March 31, 2017 | -35.33M |
| December 31, 2016 | -28.33M |
| September 30, 2016 | 49.79M |
| June 30, 2016 | -33.23M |
| March 31, 2016 | -31.91M |
| December 31, 2015 | -23.86M |
| September 30, 2015 | -7.934M |
| June 30, 2015 | -25.46M |
| March 31, 2015 | 43.59M |
| December 31, 2014 | -20.16M |
| September 30, 2014 | -14.44M |
| June 30, 2014 | -4.150M |
| March 31, 2014 | 5.886M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 3.573B |
| Xencor, Inc. | -55.66M |
| ACADIA Pharmaceuticals, Inc. | 100.78M |
| Alnylam Pharmaceuticals, Inc. | 326.72M |
| Anika Therapeutics, Inc. | -0.684M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 27.96M |
| Cash from Financing (Quarterly) | 60.17M |
| Free Cash Flow | -65.54M |
| Free Cash Flow Per Share (Quarterly) | -0.6534 |
| Free Cash Flow to Equity (Quarterly) | -134.58M |
| Free Cash Flow to Firm (Quarterly) | -37.16M |
| Free Cash Flow Yield | -24.97% |